23andMe Holding Co.

0.61
0.00 (0.61%)
At close: Mar 28, 2025, 3:59 PM
0.61%
Bid n/a
Market Cap 13.34M
Revenue (ttm) 208.78M
Net Income (ttm) -382.87M
EPS (ttm) -17.39
PE Ratio (ttm) -0.03
Forward PE -0.07
Analyst Hold
Ask n/a
Volume 29,751,445
Avg. Volume (20D) 4,158,486
Open 0.75
Previous Close 0.61
Day's Range 0.61 - 0.75
52-Week Range 0.48 - 12.76
Beta 1.20

About ME

23andMe Holding Co. operates as a consumer genetics testing company. It operates through two segments, Consumer & Research Services and Therapeutics. The Consumer & Research Services segment provides a suite of genetic reports, including information on customers' genetic ancestral origins, personal genetic health risks, and chances of passing on certain rare carrier conditions to their children, as well as reports on how genetics can impact respo...

Sector Healthcare
IPO Date Nov 23, 2020
Employees 560
Stock Exchange NASDAQ
Ticker Symbol ME
Full Company Profile

Analyst Forecast

According to 1 analyst ratings, the average rating for ME stock is "Hold." The 12-month stock price forecast is $9.4, which is an increase of 1450.39% from the latest price.

Stock Forecasts
2 weeks ago
+45.15%
23andMe shares are trading higher. The company pro... Unlock content with Pro Subscription
3 weeks ago
-59.22%
23andMe shares are trading lower after the company announced it has initiated voluntary Chapter 11 bankruptcy to pursue a strategic sale and secured $35M in DIP financing.